These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


379 related items for PubMed ID: 16504274

  • 1. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
    Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, Houvenaeghel G, Groupe des Chirurgiens de Centre de Lutte Contre le Cancer.
    Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
    [Abstract] [Full Text] [Related]

  • 2. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 3. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [Abstract] [Full Text] [Related]

  • 4. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi K, Yakushiji M.
    Gynecol Oncol; 1998 May 01; 69(2):130-6. PubMed ID: 9600820
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G, Hasenburg A.
    Gynecol Oncol; 2005 Mar 01; 96(3):658-64. PubMed ID: 15721408
    [Abstract] [Full Text] [Related]

  • 7. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
    Carcopino X, Houvenaeghel G, Buttarelli M, Esterni B, Tallet A, Goncalves A, Jacquemier J.
    Eur J Surg Oncol; 2008 May 01; 34(5):569-75. PubMed ID: 17531428
    [Abstract] [Full Text] [Related]

  • 8. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A, Magistris A, Burger RA, Monk BJ.
    Gynecol Oncol; 2004 Jul 01; 94(1):61-6. PubMed ID: 15262120
    [Abstract] [Full Text] [Related]

  • 9. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
    Azria E, Morice P, Haie-Meder C, Thoury A, Pautier P, Lhomme C, Duvillard P, Castaigne D.
    Ann Surg Oncol; 2005 Apr 01; 12(4):332-7. PubMed ID: 15827678
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar 01; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Mar 01; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K, Chie EK, Wu HG, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2006 Jun 01; 101(3):398-402. PubMed ID: 16330087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F, Sartori E, Maggino T, Zola P, Zanagnolo V, Cosio S, Ferrari F, Piovano E, Gadducci A.
    Gynecol Oncol; 2014 Mar 01; 132(3):611-7. PubMed ID: 24342439
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
    Kornovski Y, Gorchev G.
    J BUON; 2006 Mar 01; 11(3):291-7. PubMed ID: 17309152
    [Abstract] [Full Text] [Related]

  • 17. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results.
    Colombo PE, Bertrand MM, Gutowski M, Mourregot A, Fabbro M, Saint-Aubert B, Quenet F, Gourgou S, Kerr C, Rouanet P.
    Gynecol Oncol; 2009 Sep 01; 114(3):404-9. PubMed ID: 19555996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 01; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 20. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.